Skip to main content

News

By Dave Muoio | 03:08 pm | October 27, 2020
Following news that its Project Baseline program was poorly received in parts of the Bay Area, the life science company characterized site closures as more of a pause and a redirection of resources across the state.
By Laura Lovett | 02:49 pm | October 27, 2020
The new service lets patients take a digital eye exam and get their prescription renewed by an eye doctor. 
By Sara Mageit | 09:39 am | October 27, 2020
Fortunis Capital has awarded Clementine a place in its top 20 UK Impact Investment Fund.
By Sophie Porter | 03:51 am | October 27, 2020
EIS fund manager Parkwalk led the funding round alongside existing investors Jonathon Milner, Cambridge Enterprise and Martlet.
By Laura Lovett | 04:25 pm | October 26, 2020
Panelists at the World Health Summit discuss lessons learned from international collaborations during the pandemic. 
By Dave Muoio | 04:14 pm | October 26, 2020
Researchers say that their tool detected cases with 79% accuracy, and did so within minutes.
By Mallory Hackett | 01:03 pm | October 26, 2020
If the vaccine candidates stay on track, an approved vaccine could hit the market by early 2021 or sooner.
By Dave Muoio | 12:38 pm | October 26, 2020
The primary care provider is also looking to expand into virtual physical therapy in the coming year.
By Dean Koh | 01:00 am | October 26, 2020
The Savonix Mobile app is available in Japan through the company’s partnerships with Fujitsu Connected Technologies Limited and Mitani Sangyo companies.Co, Ltd.  
By Dave Muoio | 03:49 pm | October 23, 2020
The company's funding news came alongside a new deal with Humana focused on prior authorizations for musculoskeletal treatments.